Analysis of genetic risk factors for endometrial hyperplasia in overweight and obese women

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective: To study the association between single nucleotide variants (SNVs) related to body sex hormone levels and the occurrence of endometrial hyperplasia (EH) in overweight and obese women.

Materials and methods: This study included 727 women with a body mass index (BMI) ≥25 kg/m², comprising 324 patients with simple EH (glandular/glandular-cystic forms) and 403 controls. Molecular genetic analysis was conducted on four SNVs associated with sex hormone levels based on data from previous genome-wide association studies (GWAS): NC_000012.12 (ANO2):g.5902324C>A (rs117585797), NC_000016.10 (CHD9):g.52913718A>C (rs117145500), NC_000011.10 (FSHB):g.30193714T>A (rs11031002), and NC_000011.9 (SLC22A24):g.62915346C>A (rs112295236). Associations between SNVs and EH were analyzed using logistic regression.

Results: An association was found between SNV rs11031002 T>A in FSHB and EH across the three genetic models (p=0.001 and pperm=0.001): OR=0.45, 95% CI 0.31–0.66 (allelic model); OR=0.44, 95% CI 0.30–0.64 (additive model); OR=0.45, 95% CI 0.30–0.66 (dominant model). The minor allele A of SNV rs11031002 T>A in FSHB demonstrated a protective effect against disease development (OR<1). Additionally, SNV rs11031002 T>A in FSHB and five polymorphic loci (rs11031005, rs11031006, rs11031010, rs74485684, rs10835638) in linkage disequilibrium with it exhibit significant functionality, influencing the interaction of the FSHB gene promoter with 38 transcription factors and affecting the transcription level of the ARL14EP gene in subcutaneous adipose tissue.

Conclusion: SNV rs11031002 T>A in FSHB is associated with EH risk in overweight and obese women.

全文:

受限制的访问

作者简介

Vladimir Churnosov

Belgorod State National Research University

Email: vladimirchurnosov@rambler.ru
ORCID iD: 0009-0007-8519-4594

PhD student at the Department of Biomedical Disciplines

俄罗斯联邦, Belgorod

Irina Ponomarenko

Belgorod State National Research University

编辑信件的主要联系方式.
Email: ponomarenko_i@bsuedu.ru
ORCID iD: 0000-0002-5652-0166

Dr. Med. Sci., Professor at the Department of Medical and Biological Disciplines

俄罗斯联邦, Belgorod

Marina Ponomarenko

Belgorod State National Research University

Email: ponomarenkomc@yandex.ru
ORCID iD: 0009-0009-0312-0829

PhD student at the Department of Biomedical Disciplines

俄罗斯联邦, Belgorod

Mikhail Churnosov

Belgorod State National Research University

Email: churnosov@bsuedu.ru
ORCID iD: 0000-0003-1254-6134

Dr. Med. Sci., Head of the Department of Medical and Biological Disciplines

俄罗斯联邦, Belgorod

参考

  1. Cree I.A., White V.A., Indave B.I., Lokuhetty D. Revising the WHO classification: female genital tract tumours. Histopathology. 2020; 76(1): 151-6. https://dx.doi.org/10.1111/his.13977
  2. Reed S.D., Newton K.M., Clinton W.L., Epplein M., Garcia R., Allison K. et al. Incidence of endometrial hyperplasia. Am. J. Obstet. Gynecol. 2009; 200(6): 678.e1-678.e6786. https://dx.doi.org/10.1016/j.ajog.2009.02.032
  3. Протасова А.Э., Адамян Л.В., Собивчак М.С., Цыпурдеева А.А. Эндометриальная гиперплазия: современные концепции этиопатогенеза. Проблемы репродукции. 2023; 29(4): 75-80. [Protasova A.E., Adamyan L.V., Sobivchak M.S., Tsypurdeeva A.A. Endometrial hyperplasia: modern concepts of etiopathogenesis. Russian Journal of Human Reproduction. 2023; 29(4): 75 80. (in Russian)]. https://dx.doi.org/10.17116/repro20232904175
  4. Думановская М.Р., Чернуха Г.Е., Табеева Г.И., Асатурова А.В. Гиперплазия эндометрия: поиск оптимальных решений и стратегий. Акушерство и гинекология. 2021; 4: 23-31. [Dumanovskaya M.R., Chernukha G.E., Tabeeva G.I., Asaturova A.V. Endometrial hyperplasia: search for optimal solutions and strategies. Obstetrics and Gynecology. 2021; (4): 23-31. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.4.23-31
  5. Подзолкова Н.М., Коренная В.В. Современные представления об этиологии, патогенезе и принципах лечения гиперплазии эндометрия. Акушерство и гинекология. 2021; 8: 192-9. [Podzolkova N.M., Korennaya V.V. Modern ideas about the etiology, pathogenesis and principles of treatment of endometrial hyperplasia. Obstetrics and Gynecology. 2021; (8): 192-9. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.8.192-199
  6. Sanderson P.A., Critchley H.O., Williams A.R., Arends M.J., Saunders P.T. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum. Reprod. Update. 2017; 23(2): 232-54. https://dx.doi.org/10.1093/humupd/dmw042
  7. Chandra V., Kim J.J., Benbrook D.M., Dwivedi A., Rai R. Therapeutic options for management of endometrial hyperplasia. J. Gynecol. Oncol. 2016; 27(1): e8. https://dx.doi.org/10.3802/jgo.2016.27.e8
  8. Пономаренко И.В., Полоников А.В., Чурносов М.И. Гиперпластические процессы эндометрия: этиопатогенез, факторы риска, полиморфизм генов-кандидатов. Акушерство и гинекология. 2019; 1: 13-8. [Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Endometrial hyperplastic processes: etiopathogenesis, risk factors, polymorphism of candidate genes. Obstetrics and Gynecology. 2019; (1): 13-8. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.1.13-18
  9. Габидуллина Р.И., Смирнова Г.А., Нухбала Ф.Р., Валеева Е.В., Орлова Ю.И., Шакиров А.А. Гиперпластические процессы эндометрия: современная тактика ведения пациенток. Гинекология. 2019; 21(6): 53-8. [Gabidullina R.I., Smirnova G.A., Nuhbala F.R., Valeeva E.V., Orlova Y.I., Shakirov A.A. Hyperplastic processes of the endometrium: modern tactics of patient management. Gynecology. 2019; 21(6): 53-8. (in Russian)]. https://dx.doi.org/10.26442/20795696.2019.6.190472
  10. Nees L.K., Heublein S., Steinmacher S., Juhasz-Böss I., Brucker S., Tempfer C.B. et al. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch. Gynecol. Obstet. 2022; 306(2): 407-21. https://dx.doi.org/10.1007/ s00404-021-06380-5
  11. Wise M.R., Gill P., Lensen S., Thompson J.M., Farquhar C.M. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women. Am. J. Obstet. Gynecol. 2016; 215(5): 598.e1-598.e8. https://dx.doi.org/10.1016/j.ajog.2016.06.006
  12. Alsudairi H.N., Alrasheed A.T., Dvornyk V. Estrogens and uterine fibroids: an integrated view. Research Results in Biomedicine. 2021; 7(2): 156-63. https://dx.doi.org/10.18413/2658-6533-2021-7-2-0-6
  13. Ponomarenko M.S., Reshetnikov E.A., Churnosova M.M., Reshetnikova Y.N., Churnosov V.I., Ponomarenko I.V. Comorbidity and syntropy of benign proliferative diseases of the female reproductive system: non-genetic, genetic, and epigenetic factors (review). Research Results in Biomedicine. 2023; 9(4): 544-56. https://dx.doi.org/10.18413/2658- 6533-2023-9-4-0-9
  14. Demakova N.A., Altuchova O.B., Orlova V.S., Pachomov S.P., Krikun E.N. Associations of cytokines genetic polymorphisms with development of endometrial hyperplasia. Research Journal of Pharmaceutical, Biological and Chemical. 2014; 5(5): 1041-5.
  15. van der Putten L.J.M., van Hoof R., Tops B.B.J., Snijders M.P.L.M., van den Berg-van Erp S.H., van der Wurff A.A.M. et al. Molecular profiles of benign and (pre)malignant endometrial lesions. Carcinogenesis. 2017; 38(3): 329-35. https://dx.doi.org/10.1093/carcin/bgx008
  16. Altuchova O.B., Demakova N.A., Koneva O.A., Pachomov S.P., Orlova V.S., Golovchenko O.V. Genetic factors of uterine hyperplastic processes. Research Journal of Pharmaceutical, Biological and Chemical. 2014; 6(5): 1397-400.
  17. Демакова Н.А. Молекулярно-генетические характеристики пациенток с гиперплазией и полипами эндометрия. Научный результат. Медицина и фармация. 2018; 4(2): 26-39. [Demakova N.A. Molecular and genetic characteristics of patients with hyperplasia and endometric polyps. Research Result. Medicine and Pharmacy. 2018; 4(2): 26-39 (in Russian)]. https://dx.doi.org/10.18413/2313-8955-2018-4-2-0-4
  18. Ivanova T.I., Krikunova L.I., Ryabchenko N.I., Mkrtchyan L.S., Khorokhorina V.A., Salnikova L.E. Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma. Oxid. Med. Cell. Longev. 2015; 2015: 593658. https:// dx.doi.org/10.1155/2015/593658
  19. Пономаренко И.В., Полоников А.В., Чурносов М.И. Ассоциация полиморфизма rs4986938 гена ESR2 с развитием гиперплазии эндометрия. Акушерство и гинекология. 2019; 4: 66-72. [Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Association of ESR2 rs4986938 polymorphism with the development of endometrial hyperplasia. Obstetrics and Gynecology. 2019; (4): 66-72. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.4.66-72
  20. Фаткуллин И.Ф., Габидуллина Р.И., Смирнова Г.А., Нухбала Ф.Р., Валеева Е.В., Орлова Ю.И., Шакиров А.А. Ассоциация полиморфизма RS2414098 гена CYP19A1 с риском развития гиперплазии эндометрия. Акушерство и гинекология. 2020; 2: 125-30. [Fatkullin I.F., Gabidullina R.I., Smirnova G.A., Nukhbala F.R., Valeeva E.V., Orlova Yu.I., Shakirov A.A. The association between rs2414098 polymorphism of the CYP19A1 gene and the risk of developing endometrial hyperplasia. Obstetrics and Gynecology. 2020; (2): 125-30. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.2.125-130
  21. Ponomarenko I., Reshetnikov E., Polonikov A., Sorokina I., Yermachenko A., Dvornyk V. et al. Candidate genes for age at menarche are associated with endometrial hyperplasia. Gene. 2020; 757: 144933. https://dx.doi.org/10.1016/ j.gene.2020.144933
  22. Ruth K.S., Campbell P.J., Chew S., Lim E.M., Hadlow N., Stuckey B.G. et al. Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. Eur. J. Hum. Genet. 2016; 24: 284-90. https://dx.doi.org/10.1038/ejhg.2015.102
  23. Ruth K.S., Day F.R., Tyrrell J., Thompson D.J., Wood A.R., Mahajan A. et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat. Med. 2020; 26(2): 252-8. https://dx.doi.org/10.1038/ s41591-020-0751-5
  24. Gudjonsson A., Gudmundsdottir V., Axelsson G.T., Gudmundsson E.F., Jonsson B.G., Launer L.J. et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat. Commun. 2022; 13(1): 480. https://dx.doi.org/10.1038/s41467-021-27850-z
  25. Пономарева Т.А. Генетические варианты глобулина, связывающего половые гормоны, и гормональный профиль больных генитальным эндометриозом. Научные результаты биомедицинских исследований. 2025; 11(1): 75-90. [Ponomareva T.A. Genetic variants of sex hormone-binding globulin and hormonal profile in patients with genital endometriosis. Research Results in Biomedicine. 2025; 11(1): 75-90. (in Russian)]. https:// dx.doi.org/10.18413/2658-6533-2025-11-1-0-4
  26. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007; 81(3): 559-75. https:// dx.doi.org/10.1086/519795
  27. Che R., Jack J.R., Motsinger-Reif A.A., Brown C.C. An adaptive permutation approach for genome-wide association study: evaluation and recommendations for use. BioData Min. 2014; 7: 9. https://dx.doi.org/10.1186/1756-0381-7-9
  28. Пасенов К.Н. Особенности ассоциаций SHBG-связанных генов с раком молочной железы у женщин в зависимости от наличия наследственной отягощенности и мутаций в генах BRCA1/CHEK2. Научные результаты биомедицинских исследований. 2024; 10(1): 69-88. [Pasenov K.N. Features of associations of SHBG-related genes with breast cancer in women, depending on the presence of hereditary burden and mutations in the BRCA1/CHEK2 genes. Research Results in Biomedicine. 2024; 10(1): 69-88. (in Russian)]. https://dx.doi.org/10.18413/2658-6533-2024-10-1-0-4
  29. Yarosh S.L., Kokhtenko E.V., Churnosov M.I., Solodilova M.A., Polonikov A.V. Joint effect of glutathione S-transferase genotypes and cigarette smoking on idiopathic male infertility. Andrologia. 2015; 47(9): 980-6. https:// dx.doi.org/10.1111/and.12367
  30. Ward L.D., Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016; 44(D1): D877-81. https://dx.doi.org/ 10.1093/nar/gkv1340
  31. GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020; 369(6509): 1318-30. https:// dx.doi.org/10.1126/science.aaz1776
  32. McGrath I.M., Mortlock S., Montgomery G.W. Genetic regulation of physiological reproductive lifespan and female fertility. Int. J. Mol. Sci. 2021; 22(5): 2556. https://dx.doi.org/10.3390/ijms22052556
  33. Burger H.G., Hale G.E., Dennerstein L., Robertson D.M. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause. 2008; 15(4 Pt 1): 603-12. https://dx.doi.org/10.1097/ gme.0b013e318174ea4d
  34. Hambridge H.L., Mumford S.L., Mattison D.R., Ye A., Pollack A.Z., Bloom M.S. et al. The influence of sporadic anovulation on hormone levels in ovulatory cycles. Hum. Reprod. 2013; 28(6): 1687-94. https://dx.doi.org/10.1093/humrep/det090
  35. Ruth K.S., Beaumont R.N., Tyrrell J., Jones S.E., Tuke M.A., Yaghootkar H. et al. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health. Hum. Reprod. 2016; 31(2): 473-81. https://doi.org/10.1093/humrep/dev318
  36. Hayes M.G., Urbanek M., Ehrmann D.A., Armstrong L.L., Lee J.Y., Sisk R. et al.; Reproductive Medicine Network. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat. Commun. 2015; 6: 7502. https://dx.doi.org/10.1038/ncomms8502
  37. Mbarek H., van de Weijer M.P., van der Zee M.D., Ip H.F., Beck J.J., Abdellaoui A. et al. Biological insights into multiple birth: genetic findings from UK Biobank. Eur. J. Hum. Genet. 2019; 27(6): 970-9. https://dx.doi.org/10.1038/s41431-019-0355-z
  38. Pietzner M., Wheeler E., Carrasco-Zanini J., Cortes A., Koprulu M., Wörheide M.A. et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021; 374(6569): eabj1541. https://dx.doi.org/10.1126/science.abj1541
  39. Bianco B., Loureiro F.A., Trevisan C.M., Peluso C., Christofolini D.M., Montagna E. et al. Effects of FSHR and FSHB variants on hormonal profile and reproductive outcomes of infertile women with endometriosis. Front. Endocrinol. (Lausanne). 2021; 12: 616. https://dx.doi.org/10.3389/ fendo.2021.760616
  40. Rull K., Grigorova M., Ehrenberg A., Vaas P., Sekavin A., Nõmmemees D. et al. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women. Hum. Reprod. 2018; 33(5): 954-66. https://dx.doi.org/10.1093/humrep/dey057
  41. Trevisan C.M., de Oliveira R., Christofolini D.M., Barbosa C.P., Bianco B. Effects of a polymorphism in the promoter region of the follicle-stimulating hormone subunit beta (FSHB) gene on female reproductive outcomes. Genet. Test. Mol. Biomarkers. 2019; 23(1): 39-44. https://dx.doi.org/10.1089/ gtmb.2018.0182
  42. Schubert M., Pérez Lanuza L., Wöste M., Dugas M., Carmona F.D., Palomino-Morales R.J. et al. A GWAS in idiopathic/unexplained infertile men detects a genomic region determining follicle-stimulating hormone levels. J. Clin. Endocrinol. Metab. 2022; 107(8): 2350-61. https://dx.doi.org/10.1210/clinem/dgac165
  43. Tian Y., Zhao H., Chen H., Peng Y., Cui L., Du Y. et al. Variants in FSHB are associated with polycystic ovary syndrome and luteinizing hormone level in han chinese women. J. Clin. Endocrinol. Metab. 2016; 101(5): 2178-84. https://dx.doi.org/10.1210/jc.2015-3776
  44. Saxena R., Bjonnes A.C., Georgopoulos N.A., Koika V., Panidis D., Welt C.K. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume. Hum. Reprod. 2015; 30(7): 1697-703. https://dx.doi.org/10.1093/humrep/dev110

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2025